Antimicrobial Resistance and Artificial Intelligence Applications
Keywords:
AMR, artificial intelligence, antibiotic, bacterial infectionAbstract
The computational comprehension of intelligent behavior is the main goal of the scientific and engineering field of artificial intelligence (AI). Many human professions, particularly clinical diagnosis and prognosis, greatly benefit from artificial intelligence. The authorities need to take action to stop the excessive and improper the application of antibiotics to battle the increasing percentages of resistance to antibiotics since the occurrence of AMR is becoming a serious problem. In addition to causing drug resistance, the extensive using antibiotics in medical settings has raised the risk of super-resistant microorganisms. As antimicrobial resistance (AMR) increases, physicians face challenges in rapidly treating bacterial infections, and the expense of medicine may become unaffordable for patients' healthcare needs. Potential benefits include a potentially infinite speed up in the development of novel antimicrobial medications, increased precision in diagnosis and treatment, and decreased costs all at the same time, the WHO, has released a ranking of the most important dangerous infections that require the development of novel antibiotics due to the threat posed by antimicrobial resistance to global public health. The search and introduction of novel antibiotics is an expensive and time-consuming procedure. Just eighteen new antibiotics have been authorized since 2014, In line with the WHO study on clinically developed antibacterial medications. Thus, new antibiotics are desperately needed. Since its latest technological advancement, artificial intelligence (AI) has been quickly used in medication research, significantly increasing the effectiveness of discovering new antibiotics. Most AI solutions for AMR that have been proposed are designed to be useful tools to assist doctors in their work, not to take the place of a doctor's prescription or advice.
References
A. R. Collaborators, “Articles Global burden of bacterial antimicrobial resistance in 2019?: a systematic analysis,” vol. 399, 2022, doi: 10.1016/S0140-6736(21)02724-0.
A. Caneschi, A. Bardhi, A. Barbarossa, and A. Zaghini, “The Use of Antibiotics and Antimicrobial Resistance in Veterinary Medicine, a Complex Phenomenon: A Narrative Review,” Antibiotics, vol. 12, no. 3, 2023, doi: 10.3390/antibiotics12030487.
S. Khalid et al., “Journal of Medicine , Surgery , and Public Health Antimicrobial resistance?: Impacts , challenges , and future prospects,” J. Med. Surgery, Public Heal., vol. 2, no. March, p. 100081, 2024, doi: 10.1016/j.glmedi.2024.100081.
C. E. Flynn and J. Guarner, “Emerging Antimicrobial Resistance,” Mod. Pathol., vol. 36, no. 9, p. 100249, 2023, doi: 10.1016/j.modpat.2023.100249.
J. A. Al Tawfiq, S. H. Ebrahim, and Z. A. Memish, “Preventing Antimicrobial Resistance Together?: Reflections on AMR Week 2023,” J. Epidemiol. Glob. Health, vol. 14, no. 2, pp. 249–251, 2024, doi: 10.1007/s44197-023-00178-1.
J. Denissen et al., “International Journal of Hygiene and Environmental Health Prevalence of ESKAPE pathogens in the environment?: Antibiotic resistance status , community-acquired infection and risk to human health,” Int. J. Hyg. Environ. Health, vol. 244, no. June, p. 114006, 2022, doi: 10.1016/j.ijheh.2022.114006.
D. Vijay, G. Angad, and D. Veterinary, “STUDY ON ANTIMICROBIAL USAGE , RESISTANCE AND RESIDUES IN DAIRY HERDS OF PUNJAB USING A ‘ ONE - HEALTH ’ APPROACH Guru Angad Dev Veterinary and Animal Sciences University,” 2022.
C. L. Ventola, “The Antibiotic Resistance Crisis Part 1?: Causes and Threats,” vol. 40, no. 4, pp. 277–283, 2015.
M. I. Hutchings, A. W. Truman, and B. Wilkinson, “ScienceDirect Antibiotics?: past , present and future,” Curr. Opin. Microbiol., vol. 51, no. Figure 1, pp. 72–80, 2020, doi: 10.1016/j.mib.2019.10.008.
L. Katz and R. H. Baltz, “Natural product discovery?: past , present , and future,” J. Ind. Microbiol. Biotechnol., vol. 43, no. 2, pp. 155–176, 2016, doi: 10.1007/s10295-015-1723-5.
G. Y. Liu et al., “Antimicrobial resistance crisis?: could artificial intelligence be the solution??,” Mil. Med. Res., pp. 1–23, 2024, doi: 10.1186/s40779-024-00510-1.
C. Fu and Q. Chen, “Jo ur na l P re f,” J. Pharm. Anal., p. 101248, 2025, doi: 10.1016/j.jpha.2025.101248.
Z. Mariam, “Artificial intelligence in drug development?: reshaping the therapeutic landscape,” 2025, doi: 10.1177/20420986251321704.
S. Aritra, C. Baghel, and S. Indu, “Harnessing the power of arti fi cial intelligence in pharmaceuticals?: Current trends and future prospects,” Intell. Pharm., no. April 2022, 2025, doi: 10.1016/j.ipha.2024.12.001.
A. M. Mohammed et al., “South African Journal of Chemical Engineering Enhancing antimicrobial resistance strategies?: Leveraging artificial intelligence for improved outcomes,” vol. 51, no. August 2024, pp. 272–286, 2025.
S. M. Hoy, “Contezolid?: First Approval,” Drugs, pp. 1587–1591, 2021, doi: 10.1007/s40265-021-01576-0.
L. L. Silver, N. Ohmagari, R. Kozlov, and S. Harbarth, “Analysis of the Clinical Pipeline of Treatments for Drug- Resistant Bacterial Infections?: Despite Progress , More Action Is,” vol. 66, no. 3, pp. 1–20, 2022.
N. I. Combinations, “crossm,” vol. 30, no. ii, 2021.
J. Lv, S. Deng, and L. Zhang, “Biosafety and Health A review of arti fi cial intelligence applications for antimicrobial resistance,” vol. 3, pp. 22–31, 2021, doi: 10.1016/j.bsheal.2020.08.003.
K. P. Murphy, “Naive Bayes classifiers Generative classifiers,” pp. 1–8, 2006.
A. Sakagianni et al., “Using Machine Learning to Predict Antimicrobial Resistance — A Literature Review,” pp. 1–18, 2023.
P. Rezaei-hachesu, T. Samad-soltani, S. Yaghoubi, and M. Ghazisaeedi, “International Journal of Medical Informatics The design and evaluation of an antimicrobial resistance surveillance system for neonatal intensive care units in Iran,” vol. 115, no. April, pp. 24–34, 2018.
M. Choisy et al., “Assessing antimicrobial misuse in small-scale chicken farms in Vietnam from an observational study,” pp. 1–10, 2019.
J. R. Quinlan, “Induction of Decision Trees,” pp. 81–106, 2007.
Y. Zhuang and C. Singh, “Learning a Decision Tree Algorithm with Transformers,” pp. 1–24, 2024.
J. R. Quinlan, “J. R. Quinlan,” vol. 5, no. Quinlan 1993, 2006.
M. Segal and M. Biostatistics, “Tree Depth in a Forest.”
N. R. Naylor, N. Zhu, M. Hulscher, A. Holmes, R. Ahmad, and J. V Robotham, “Is antimicrobial stewardship cost-effective?? A narrative review of the evidence,” Clin. Microbiol. Infect., vol. 23, no. 11, pp. 806–811, 2017, doi: 10.1016/j.cmi.2017.06.011.
N. R. Naylor et al., “Estimating the burden of antimicrobial resistance?: a systematic literature review,” pp. 1–17, 2018.
C. A. Reynolds, J. A. Finkelstein, G. T. Ray, M. R. Moore, and S. S. Huang, “Attributable healthcare utilization and cost of pneumoniae due to drug-resistant Streptococcus pneumoniae?: a cost analysis Attributable healthcare utilization and cost of pneumoniae due to drug-resistant Streptococcus pneumoniae?: a cost analysis,” 2014.
A. Shajiei et al., “Impact of reduced antibiotic treatment duration on antimicrobial resistance in critically ill patients in the randomized controlled SAPS-trial.”
A. Liaw and M. Wiener, “Classification and Regression by randomForest,” vol. 2, no. December, pp. 18–22, 2002.
L. E. O. Breiman, “Random Forests,” pp. 5–32, 2001.
S. Chandrasekaran, M. Cokol-cakmak, N. Sahin, K. Yilancioglu, and H. Kazan, “Chemogenomics and orthology-based design of antibiotic combination therapies,” pp. 1–12, 2016, doi: 10.15252/msb.20156777.
R. J. Nichols et al., “Resource Phenotypic Landscape of a Bacterial Cell,” Cell, vol. 144, no. 1, pp. 143–156, 2011, doi: 10.1016/j.cell.2010.11.052.
I. Karakoc, S. Meral, N. Kuru, A. Bender, and M. Cokol, “Prediction of antibiotic interactions using descriptors derived from compound molecular structure,” 2017.
J. Vandewalle, “Least Squares Support Vector Machine Classifiers,” pp. 293–300, 1999.
“No Title.”
Z. Liu, D. Deng, H. Lu, J. Sun, L. Lv, and S. Li, “Evaluation of Machine Learning Models for Predicting Antimicrobial Resistance of Actinobacillus pleuropneumoniae From Whole Genome Sequences,” vol. 11, no. February, pp. 1–7, 2020, doi: 10.3389/fmicb.2020.00048.
R. Dastres, M. Soori, A. Neural, N. Systems, and I. Journal, “Artificial Neural Network Systems To cite this version?: HAL Id?: hal-03349542,” vol. 21, no. 2, pp. 13–25, 2021.
J. M. Stokes et al., “Article A Deep Learning Approach,” Cell, vol. 180, no. 4, pp. 688-702.e13, 2020, doi: 10.1016/j.cell.2020.01.021.
J. Lv, S. Deng, and L. Zhang, “Biosafety and Health A review of arti fi cial intelligence applications for antimicrobial resistance,” vol. 3, pp. 22–31, 2021.
I. Yelin et al., “tract infections,” vol. 25, no. 7, pp. 1143–1152, 2020, doi: 10.1038/s41591-019-0503-6.Personal.
R. Steinkey, J. Moat, V. Gannon, A. Zovoilis, and C. Laing, “Application of artificial intelligence to the in silico assessment of antimicrobial resistance and risks to human and animal health presented by priority enteric bacterial pathogens,” vol. 46, no. 6, pp. 180–185, 2020.
E. Elyan, A. Hussain, A. Sheikh, and A. A. Elmanama, “Antimicrobial Resistance and Machine Learning?: Challenges and Opportunities,” IEEE Access, vol. 10, pp. 31561–31577, 2022, doi: 10.1109/ACCESS.2022.3160213.
M. N. Anahtar, J. H. Yang, and S. Kanjilal, “Applications of Machine Learning to the Problem of Antimicrobial Resistance?: an Emerging Model for Translational.”
D. Yakar, Y. P. Ongena, T. C. Kwee, and M. Haan, “Do People Favor Artificial Intelligence Over Physicians? A Survey Among the General Population and Their View on Artificial Intelligence in Medicine,” Value Heal., vol. 25, no. 3, pp. 374–381, 2021, doi: 10.1016/j.jval.2021.09.004.
C. Pharmacology, “Artificial Intelligence Technologies in Cardiology,” 2023.
V. Baxi, R. Edwards, M. Montalto, and S. Saha, “Digital pathology and arti fi cial intelligence in translational medicine and clinical practice,” Mod. Pathol., vol. 35, no. 1, pp. 23–32, 2021, doi: 10.1038/s41379-021-00919-2.
T. M. Rawson, R. Ahmad, C. Toumazou, P. Georgiou, and A. H. Holmes, “Artificial intelligence can improve decision-.”
T. Wang, X. Wan, and S. Yao, “Better AMR-To-Text Generation with Graph Structure Reconstruction,” pp. 3919–3925.
L. Hadjadj, M. A. Syed, J. Bushra, S. A. Abbasi, J. Rolain, and B. Daltonics, “Letter to the Editor,” vol. 20, no. X, pp. 20–21, 2019, doi: 10.1089/sur.2019.005.
W. U. Hospital, “Comment COVID-19 drug practices risk antimicrobial resistance evolution,” pp. 2020–2021, 2020, doi: 10.1016/S2666-5247(21)00039-2.
U. Fanelli et al., “Role of Artificial Intelligence in Fighting Antimicrobial Resistance in Pediatrics,” pp. 1–12, 2020.
F. Petropoulos et al., “Forecasting?: theory and practice,” Int. J. Forecast., vol. 38, no. 3, pp. 705–871, 2022, doi: 10.1016/j.ijforecast.2021.11.001.
D. A. K. Id et al., “An attention based deep learning model of clinical events in the intensive care unit,” pp. 1–17, 2019, doi: 10.5281/zenodo.1473691.
K. Mikrobiyoloji, L. Yapay, and Z. Uygulamalar?, “REVIEW / DERLEME Artificial Intelligence Applications In Clinical Microbiology Laboratory,” vol. 9, no. 1, 2024, doi: 10.58854/jicm.1404800.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 International Journal of Sciences: Basic and Applied Research (IJSBAR)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who submit papers with this journal agree to the following terms.
